Interestingly, the authors found that combinatorial therapies with CDK inhibitor and a small molecule that inhibited the production of these SMO-activating lipids was able to effectively block cancer cell growth and may help overcome resistance to monotherapy. The gene discussed is SMO; the disease is cancer.